Literature DB >> 18399818

Spreading depression enhances human neocortical excitability in vitro.

M Berger1, E-J Speckmann, H C Pape, A Gorji.   

Abstract

Cortical spreading depression (CSD) plays a role in migraine with aura. However, studies of the neuronal effects of CSD in human cortex are scarce. Therefore, in the present study, the effects of CSD on the field excitatory postsynaptic potentials (fEPSP) and the induction of long-term potentiation (LTP) were investigated in human neocortical slices obtained during epilepsy surgery. CSD significantly enhanced the amplitude of fEPSP following a transient suppressive period and increased the induction of LTP in the third layer of neocortical tissues. These results indicate that CSD facilitates synaptic excitability and efficacy in human neocortical tissues, which can be assumed to contribute to hyperexcitability of neocortical tissues in patients suffering from migraine.

Entities:  

Mesh:

Year:  2008        PMID: 18399818     DOI: 10.1111/j.1468-2982.2008.01556.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  33 in total

Review 1.  Headache and ADHD in Pediatric Age: Possible Physiopathological Links.

Authors:  Maria Chiara Paolino; Alessandro Ferretti; Maria Pia Villa; Pasquale Parisi
Journal:  Curr Pain Headache Rep       Date:  2015-07

2.  Potentiation of spontaneous and evoked cortical electrical activity after spreading depression: in vivo analysis in well-nourished and malnourished rats.

Authors:  Thays Kallyne Marinho de Souza; Mariana Barros e Silva; André Ricardson Gomes; Hélio Magalhães de Oliveira; Renato Barros Moraes; Catão Temístocles de Freitas Barbosa; Rubem Carlos Araújo Guedes
Journal:  Exp Brain Res       Date:  2011-08-24       Impact factor: 1.972

3.  Unilateral cortical spreading depression affects sleep need and induces molecular and electrophysiological signs of synaptic potentiation in vivo.

Authors:  Ugo Faraguna; Aaron Nelson; Vladyslav V Vyazovskiy; Chiara Cirelli; Giulio Tononi
Journal:  Cereb Cortex       Date:  2010-03-26       Impact factor: 5.357

4.  The first phase of a migraine attack resides in the cortex.

Authors:  Hayrunnisa Bolay
Journal:  J Neural Transm (Vienna)       Date:  2012-03-18       Impact factor: 3.575

5.  Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache.

Authors:  A Laine Green; Pengfei Gu; Milena De Felice; David Dodick; Michael H Ossipov; Frank Porreca
Journal:  Cephalalgia       Date:  2013-12-11       Impact factor: 6.292

6.  Spatial frequency differentially affects habituation in migraineurs: a steady-state visual-evoked potential study.

Authors:  Koichi Shibata; Kiyomi Yamane; Yoshiko Nishimura; Hiromi Kondo; Kuniaki Otuka
Journal:  Doc Ophthalmol       Date:  2011-07-19       Impact factor: 2.379

7.  Is spreading depolarization characterized by an abrupt, massive release of gibbs free energy from the human brain cortex?

Authors:  Jens P Dreier; Thomas Isele; Clemens Reiffurth; Nikolas Offenhauser; Sergei A Kirov; Markus A Dahlem; Oscar Herreras
Journal:  Neuroscientist       Date:  2012-07-24       Impact factor: 7.519

8.  Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Nilufer Yalcin; Esther S Yu; Ali Daneshmand; Ying Wei; Yi Zheng; Anil Can; Buse Sengul; Michel D Ferrari; Arn M J M van den Maagdenberg; Cenk Ayata
Journal:  Stroke       Date:  2014-11-25       Impact factor: 7.914

Review 9.  About sleep's role in memory.

Authors:  Björn Rasch; Jan Born
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

10.  Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1.

Authors:  Katharina Eikermann-Haerter; Ergin Dileköz; Chiho Kudo; Sean I Savitz; Christian Waeber; Michael J Baum; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.